L250-1597 Screening compound: 2-{1-[2-(4-methylphenyl)-1,3-benzoxazole-6-carbonyl]piperidin-4-yl}-N-[(pyridin-3-yl)methyl]acetamide

L250-1597 Screening compound: 2-{1-[2-(4-methylphenyl)-1,3-benzoxazole-6-carbonyl]piperidin-4-yl}-N-[(pyridin-3-yl)methyl]acetamide
L250-1597 Screening compound: 2-{1-[2-(4-methylphenyl)-1,3-benzoxazole-6-carbonyl]piperidin-4-yl}-N-[(pyridin-3-yl)methyl]acetamide alternative view

Chemical Structure Depiction of ChemDiv screening compound L250-1597
2-{1-[2-(4-methylphenyl)-1,3-benzoxazole-6-carbonyl]piperidin-4-yl}-N-[(pyridin-3-yl)methyl]acetamide

Available from 1 mg

Formats:

  • Glass Vials (4ml Glass Vials VWR #97047-678)
  • 96-tube racks (Matrix #4247 96-well 1.4ml sealed with capmats, empty cols 1 & 12, 100uL of 10mM)

Shiptime: 1 week worldwide delivery in most cases

Compound Identifiers

ChemDiv Compound ID

L250-1597

Molecular Formula

C28H28N4O3 (C28 H28 N4 O3)

Compound Name

2-{1-[2-(4-methylphenyl)-1,3-benzoxazole-6-carbonyl]piperidin-4-yl}-N-[(pyridin-3-yl)methyl]acetamide

IUPAC name

2-{1-[2-(4-methylphenyl)-13-benzoxazole-6-carbonyl]piperidin-4-yl}-N-[(pyridin-3-yl)methyl]acetamide

SMILES

Cc(cc1)ccc1-c1nc(ccc(C(N2CCC(CC(NCc3cnccc3)=O)CC2)=O)c2)c2o1

InChI

InChI=1S/C28H28N4O3/c1-19-4-6-22(7-5-19)27-31-24-9-8-23(16-25(24)35-27)28(34)32-13-10-20(11-14-32)15-26(33)30-18-21-3-2-12-29-17-21/h2-9,12,16-17,20H,10-11,13-15,18H2,1H3,(H,30,33)

InChI Key

YMASNNGHOFQSNS-UHFFFAOYSA-N

MDL Number (MFCD)

MFCD15120984

Chemical and Physical Properties

Saltdata

n/a

Molecular Weight

468.56

Hydrogen Bond Acceptors Count

7.00

Hydrogen Bond Donors Count

1.00

Rotatable Bond Count

8.00

Number of Nitrogen and Oxygen Atoms

7

Partition Coefficient, logP

3.494

Distribution Coefficient, logD

3.492

Water Solubility, LogSw

-3.31

Polar Surface Area

67.415

Acid Dissociation Constant (pKa)

13.61

Base Dissociation Constant (pKb)

5.15

Number of Chiral Centers

0.00

Percent sp3 carbon bonding

28.60

L250-1597 in Drug Discovery

Included in Screening Libraries

CNS Targets (44014 compounds)

MCL1 Targeted Library (12200 compounds)

Serine Proteases Inhibitors Library (32732 compounds)

Included in 1.7M Stock Database

Therapeutical areas:
  • Nervous system
  • Digestive system
  • Respiratory tract
  • Male
  • Female
  • Hemic and lymphatic
  • Infections
  • Cancer
  • Musculoskeletal
  • Digestive system
  • Respiratory tract
  • Male
  • Female
  • Cardiovascular
  • Skin
  • Metabolic
  • Immune system
Targets:
  • Proteases

References: we are preparing a list of scientific research reports with L250-1597 chemical compound. It will be published here after verification.

Frequently Asked Questions

How to purchase chemical compound L250-1597?
Check Price and Availability of L250-1597, then you can add required amount to the Shopping Cart. In the Shopping Cart you can again refine your selection. Once you are sure that it’s exactly what you want you can move forward with the Checkout (to pay online by credit card, or via PayPal), or Request a Quote.
What is the minimum amount of L250-1597 you sell to drug discovery company or institution?
Available from 1 mg in Glass Vials or 96-tube racks.
Delivery options for L250-1597
ChemDiv sends parcels with Express services (UPS, WC).
  • 1–2 days for small orders
  • 2–4 weeks for large selections
Delivery formats for L250-1597
  • 0.5–50 mg of dry powder sample in single glass vials, custom vials
  • DMSO solutions frozen 10μl–250μl@10mM (96 and 384 format)

Custom synthesis of L250-1597 available by request